Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Total Non-Current Liabilities (2019 - 2025)

Cresco Labs' Total Non-Current Liabilities history spans 7 years, with the latest figure at $844.6 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 3.23% year-over-year to $844.6 million; the TTM value through Dec 2025 reached $844.6 million, down 3.23%, while the annual FY2025 figure was $844.6 million, 3.23% down from the prior year.
  • Total Non-Current Liabilities reached $844.6 million in Q4 2025 per CRLBF's latest filing, down from $872.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $872.8 million in Q4 2024 to a low of $694.3 million in Q4 2021.
  • Average Total Non-Current Liabilities over 5 years is $776.4 million, with a median of $740.1 million recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: soared 71.69% in 2021, then dropped 3.23% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $694.3 million in 2021, then increased by 6.6% to $740.1 million in 2022, then fell by 1.35% to $730.2 million in 2023, then rose by 19.54% to $872.8 million in 2024, then fell by 3.23% to $844.6 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Total Non-Current Liabilities are $844.6 million (Q4 2025), $872.8 million (Q4 2024), and $730.2 million (Q4 2023).